首页> 外文期刊>Oncology letters >Efficacy of thoracoscopic surgery in the treatment of lung cancer in the perioperative period and its effects on serum D-dimer
【24h】

Efficacy of thoracoscopic surgery in the treatment of lung cancer in the perioperative period and its effects on serum D-dimer

机译:胸腔镜手术在围手术期肺癌治疗中的疗效及其对血清D二聚体的影响

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The aim of this study was to investigate the feasibility and safety of thoracoscopic surgery in the treatment of lung cancer and its effect on serum D-dimer. A total of 218 patients with lung cancer treated in the Department of Thoracic Surgery of Ningbo No. 2 Hospital from January 1, 2013 to December 31, 2016, were retrospectively analyzed. Of the 218 patients, 120 patients underwent thoracotomy (thoracotomy group) and 98 patients underwent thoracoscopic surgery (thoracoscopy group). The clinical efficacy in the perioperative period and serum D-dimer level were compared between the two groups. In the present study, the intraoperative blood loss, blood transfusion rate, postoperative hospital stay, thoracic drainage time and volume in the thoracoscopy group were significantly shorter or smaller than those in the thoracotomy group (P< 0.05), but there was no statistically significant difference in the average operation time between the thoracoscopy and the thoracotomy group. The incidence rate from moderate to severe pains in incisions after operation, the use rate of analgesics and the average disappearance time of the pain in incisions in the thoracoscopy were lower than those in the thoracotomy group (P< 0.05). The amount of serum D-dimer immediately after operation in the thoracotomy group was significantly increased compared with that before operation (P< 0.05), but there was no significant increase in the thoracoscopy group. At 24 h after operation, the serum D-dimer level in the two groups was further increased (P< 0.05), and the comparison between the two groups showed that the levels of serum D-dimer in the thoracoscopy group immediately and at 24 h after operation were significantly lower than those in the thoracotomy group (P< 0.05). The incidence rate of postoperative complications in the thoracoscopy was lower than that in the thoracotomy group, but the difference was not statistically significant. Our results show that thoracoscopic surgery is feasible and safe in the treatment of lung cancer. Compared with the thoracotomy group, the intraoperative condition and postoperative recovery have obvious advantages. The postoperative blood of patients is hypercoagulable and D-dimer increased gradually after 24 h. The effect of thoracoscopic surgery on serum D-dimer is relatively less effective.
机译:本研究的目的是探讨胸腔镜手术治疗肺癌的可行性和安全性及其对血清D-二聚体的影响。回顾性分析了2013年1月1日至2016年12月31日宁波第2届医院胸部手术部分别治疗的218例肺癌患者。在218名患者中,120名患者接受了胸廓术(胸廓术)和98例胸腔镜手术(胸腔镜检查)。在两组之间比较围手术期和血清D-二聚体水平的临床疗效。在本研究中,胸腔镜检查组术中失血,血液输血率,术后医院住院,胸腔引流时间和体积显着短或小于胸廓切开术(P <0.05),但没有统计学意义胸腔镜检查与胸廓切开术之间的平均操作时间差异。在手术后,中度至严重疼痛的发病率,镇痛药的使用率和胸腔镜检查中切口疼痛的平均消失时间低于胸廓术中的疼痛(P <0.05)。在胸廓术中操作后立即血清D-二聚体的量明显增加,与手术前相比显着增加(P <0.05),但胸腔镜检查没有显着增加。在24小时后,两组中的血清D-二聚体水平进一步增加(P <0.05),两组之间的比较显示,胸腔镜检查的血清D-二聚体水平立即和24小时术后明显低于胸廓切开术中的术(P <0.05)。胸腔镜检查术后并发症的发病率低于胸廓术中的并发症,但差异没有统计学意义。我们的研究结果表明,胸腔镜手术是可行和安全的肺癌。与胸廓术群相比,术中条件和术后恢复具有明显的优势。患者的术后血液是高凝血液,24小时后逐渐增加。胸腔镜手术对血清D-二聚体的影响是相对较低的效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号